Medical tourism has long promised affordable treatment options across borders, but for many patients, the journey still begins with uncertainty—unclear pricing, unreliable listings, and too many middlemen. CureMeAbroad wants to change that.
The medical tourism discovery platform has raised $600,000 in a pre-seed funding round from a group of notable angel investors including Roman Saini, Himanshu Ratnoo, Kunal Gupta, Devaiah Bopanna, and Vikrant Potnis.
The fresh capital will be used to strengthen the company’s technology stack, with a clear focus on improving patient decision-making. This includes expanding its AI-powered cost estimator, enhancing clinical matching models, and building a multilingual patient intelligence layer that powers its discovery engine.
Founded in June 2025 by Aditya Oza and Mikhail Bohra, CureMeAbroad is positioning itself as an AI-first platform that helps international patients discover the right hospitals, surgeons, and destinations based on treatment needs and budget preferences.
At a time when the global medical tourism market is expected to touch $174 billion by 2035, the startup is betting that trust and transparency will define the next phase of industry growth.
The platform says it currently hosts a directory of more than 6,000 hospitals across 47 countries and 45 specialties, while actively working with over 380 accredited partner hospitals in leading medical tourism destinations such as India, Thailand, Turkey, Mexico, and Georgia.
CureMeAbroad is also looking to scale in major source markets including the GCC, UK, and Africa, where patients increasingly explore overseas healthcare options for affordability and faster access.
The startup aims to solve persistent gaps in the sector—opaque pricing, dependence on informal WhatsApp agents, unverified clinic listings, and limited post-treatment accountability.
As competition grows from global players such as Bookimed, PlacidWay, The Medical Tourism Company, and Medical Departures, CureMeAbroad is betting that an AI-led, trust-first model can help it stand apart.
With healthcare choices becoming more global, platforms that simplify discovery and build confidence may shape the future of cross-border treatment—and CureMeAbroad wants to be one of them.
-By Muskan Dengra
